Longeveron Inc.LGVNEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
Longeveron Inc. is a clinical-stage biotechnology company specializing in regenerative medicine therapies for aging-related and life-threatening conditions. Its lead candidate targets geriatric frailty, Alzheimer's disease, and cardiovascular disorders, with core operations focused on the U.S. biopharmaceutical market.